BRIEF published on 09/25/2024 at 17:50, 1 year 2 months ago Zuanic & Associates Initiates Coverage of LFTD Partners Inc. With a Rating of Overweight Equity Research Hemp Products LFTD Partners Zuanic & Associates Overweight Rating
PRESS RELEASE published on 09/25/2024 at 17:45, 1 year 2 months ago Zuanic & Associates Initiates Coverage of LFTD Partners Inc. With a Rating of Overweight LFTD Partners Inc., the parent of Urb, receives Overweight rating from Zuanic & Associates. Detailed report available. Analyst covers cannabis, CBD, hemp industries Cannabis Industry Equity Research LFTD Partners Inc. Zuanic & Associates Overweight Rating
BRIEF published on 09/12/2024 at 13:05, 1 year 2 months ago Take Off: Urb Launches New "Fly High" Brand Identity and Loyalty Program Cannabinoids Loyalty Program Urb Fly High Vapes
PRESS RELEASE published on 09/12/2024 at 13:00, 1 year 2 months ago Take Off: Urb Launches New "Fly High" Brand Identity and Urb Miles Loyalty Program LFTD Partners Inc.'s Urb introduces 'Fly High' brand and Urb Miles loyalty program at Urb.shop, offering premium cannabinoids, terpenes, edibles, vapes, and unique smoking accessories Cannabinoids Loyalty Program LFTD Partners Inc. Urb Fly High
BRIEF published on 08/15/2024 at 12:50, 1 year 3 months ago LFTD Partners Inc. Reports Second Quarter 2024 Financial Results Financial Results Revenue Decrease Net Loss Balance Sheet Second Quarter
PRESS RELEASE published on 08/15/2024 at 12:45, 1 year 3 months ago LFTD Partners Inc. Reports Second Quarter 2024 Financial Results LFTD Partners Inc. reports financial results for Q2 2024, showing decline in revenue and net income. Balance reflects decrease in cash, inventory, and working capital Financial Results Revenue Decline Balance Sheet Q2 2024 LFTD Partners Inc.
BRIEF published on 08/12/2024 at 16:05, 1 year 3 months ago LFTD Partners Inc. to Host Second Quarter 2024 Earnings Conference Call on August 15, 2024 Financial Results Conference Call Webcast LFTD Partners Q2 Earnings
PRESS RELEASE published on 08/12/2024 at 16:00, 1 year 3 months ago LFTD Partners Inc. to Host Second Quarter 2024 Earnings Conference Call on August 15, 2024 LFTD Partners Inc. to release Q2 2024 financial results and host earnings conference call on August 15, 2024. Visit website for details and submit questions in advance Financial Results Investor Relations Earnings Conference Call LFTD Partners Inc. Lifted Made
BRIEF published on 06/17/2024 at 06:05, 1 year 5 months ago LFTD Partners Inc. Applauds Governor DeSantis for Vetoing Hemp Bill LFTD Partners Hemp Industry Governor DeSantis Senate Bill 1698 Florida Economy
PRESS RELEASE published on 06/17/2024 at 06:00, 1 year 5 months ago LFTD Partners Inc. Applauds Florida Governor DeSantis for Veto of Jobs-Destroying Hemp Bill LFTD Partners Inc. praises Governor DeSantis for vetoing SB 1698, preventing the shutdown of 5,000 businesses and preserving jobs and tax revenue in Florida Florida LFTD Partners Inc. Governor DeSantis Veto SB 1698
Published on 12/05/2025 at 02:35, 5 hours 26 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 1 minute ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 56 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 1 minute ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 30 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 10 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 35 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 46 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 14 hours 1 minute ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 16 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago Declaration of voting rights at the end of November 2025
